Follow-up after surgery for colorectal liver metastasis: the prospective multicentre FUTURE-mets study

Recruiting

• Conditions: Colon cancer metastasized to the liver; colorectal liver metastases; 10019815

• Registration Number: NL-OMON52640
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 138

Inclusion Criteria

- Patients with CRLM treated with curative intent
- Age >= 18 years
- ECOG performance status <= 2
- Histologically confirmed and previously resected primary colorectal carcinoma
- Disease-free at three to six months after CRLM treatment (assessed by medical
imaging)
- Disease-free at three to six months after treatment for colorectal metastases
and a history of CRLM (assessed by medical imaging)

Exclusion Criteria

- Metastatic extrahepatic disease (EHD) precluding curative treatment of CRLM
- Patients with confirmed hereditary CRC
- Patients enrolled in other studies that require strict adherence to any
specific follow-up practice with regular imaging - yearly or more frequent - of
the abdomen and/or thorax
- Patients with comorbidity that requires imaging of the abdomen and/or thorax
every year or more frequent
- Inability to complete the questionnaires due to illiteracy and/or
insufficient proficiency of the Dutch language

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome of this trial is the quality of life. The effect of<br /><br>follow-up on health related quality of life will be assessed by the validated<br /><br>European Organisation for Research and Treatment of Cancer core quality of life<br /><br>questionnaire (EORTC QLQ-C30).</p><br>